Analysts

Analysts Bank of America raised Apple (AAPL) target price to $380, citing AI shift as a growth opportunity

05/26/2026, 10:36 AM investing rating_growth Analysts: analysts, Bank of America ai software Apple

Bank of America has upgraded its outlook on Apple, raising its price target to $380, citing the company's potential to leverage artificial intelligence advancements through its user data control.

Analysts Roth highlight bullish sentiment in space stocks following SpaceX’s IPO filing

05/26/2026, 10:36 AM investing review Analysts: analysts, Cantor Fitzgerald space finance VanEck Intuitive Machines Rocket Lab

The recent filing for SpaceX's IPO has ignited a significant rally in space stocks, attracting retail investors eager to capitalize on what could be the largest IPO in history. This surge is benefiting both direct competitors and suppliers within the space sector, indicating a broader bullish sentiment in the market.

Analysts recommend buying Marvell Technology (MRVL) shares on pullback strategy ahead of earnings

05/26/2026, 10:36 AM investing recommendation Analysts: analysts semiconductors Marvell Technology

Marvell Technology (MRVL) has seen significant stock price increases due to strong demand in AI infrastructure and custom silicon, but caution is advised ahead of its upcoming earnings report due to high valuations and market expectations.

Analysts UBS raised Micron Technology (MU) target price to $1,625 on strong AI demand for memory chips

05/26/2026, 08:34 AM economy rating_growth Analysts: analysts, UBS ai semiconductors Micron Technology

Micron's stock surged 18%, pushing its market value past $1 trillion for the first time, fueled by strong demand for memory chips driven by artificial intelligence applications. UBS's significant price target increase reflects optimism about Micron's growth potential in the evolving tech landscape.

Analysts Ritholtz Wealth Management highlight CSX Corp. (CSX) as a top stock in the transport sector amid market volatility

05/26/2026, 08:34 AM investing review Analysts: analysts, Ritholtz industrials CSX Corporation

The transportation sector has shown strong performance despite recent volatility, with key players like CSX and Union Pacific poised for growth amid ongoing mergers and operational improvements. Investors should pay attention to these developments as they could significantly impact stock valuations in the sector.

Analysts recommend a bull call spread strategy for Northrop Grumman (NOC) amid recent price decline

05/26/2026, 08:34 AM investing recommendation Analysts: analysts defense Northrop Grumman

Northrop Grumman's stock has dropped 30% in less than two months, but technical indicators suggest a potential turnaround, making it a point of interest for investors looking for entry opportunities.

Analysts Goldman Sachs initiate coverage of Hemab Therapeutics (HEMA) with Buy rating and $36 target price, citing potential for unique bleeding disorder treatment

05/26/2026, 07:32 AM investing rating_growth Analysts: analysts, Goldman Sachs biotech

Hemab Therapeutics is positioned for significant growth following its IPO, driven by its development of unique treatments for rare bleeding disorders, as highlighted by Goldman Sachs' bullish outlook.

Analysts Yardeni Research highlight 'FEMO' as a key driver of stock market growth amid geopolitical concerns

05/26/2026, 06:31 AM investing research Analysts: analysts finance

The stock market's recent gains are attributed to 'FEMO' or 'fabulous earnings momentum,' as strong earnings growth drives investor confidence despite geopolitical concerns. This trend suggests a robust outlook for future profits, influencing market behavior significantly.

Analysts Citi recommend buying Pershing Square (PS) shares with a target price of $50, indicating potential upside of around 40%

05/26/2026, 05:34 AM investing recommendation Analysts: analysts, Citi Pershing Square Capital Management

Pershing Square's stock has surged over 27% since its IPO, raising concerns among analysts about its high valuation despite positive attributes. This situation presents a mixed outlook for investors as they weigh potential growth against elevated prices.

Analysts UBS upgrade Vipshop (VIPS) to Buy, while JPMorgan initiates coverage on Seaport Therapeutics (SPTX) with Overweight rating

05/26/2026, 05:34 AM investing review Analysts: analysts, JPMorgan, UBS

Several major Wall Street firms have made significant upgrades and initiations on various stocks, reflecting optimism in sectors like e-commerce, biotechnology, and technology, which could influence investor sentiment and market dynamics.